A small number of HIV-infected cells remain in the tissues of people living with the virus and who are undergoing antiretroviral therapy. These viral reservoirs, real obstacles to the cure of HIV, have long been known...
In recent years, we’ve witnessed some truly inspiring progress in vaccine development. That includes the mRNA vaccines that were so critical during the COVID-19 pandemic, the first approved vaccine for respiratory...
To many, EV stands for “electric vehicle.” To researchers at Harvard University and the University of Nebraska–Lincoln, it’s shorthand for another vehicle — this one nanoscopic — that might help streamline the...
National HIV treatment programmes should not wait until people with HIV have viral loads above 1000 copies/ml to provide enhanced adherence counselling, Nigerian researchers report in the journal Lancet Global Health...
A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced. The vaccine showed success in stimulating production of rare immune cells...
A regional corner of Africa is a hotspot for cases of HIV, tuberculosis and malaria, prompting researchers to call for targeted health support rather than a national response. The new research, published in BMJ Global...
First steps towards protection from the many and variable viral strains Volunteers in the US recently received the first experimental doses of a new type of HIV vaccine. Using Moderna’s mRNA platform, the vaccine has...
About two decades after first devising a new kind of vaccine, Oregon Health & Science University (OHSU) researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half...
Scientists are engineering vaccines that turn cells into antibody factories The Conference on Retroviruses and Opportunistic Infections (CROI 2020) heard this week how scientists had, for the first time, devised a...
An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety...